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t is increasingly becoming recognized that
somatic and psychiatric disorders frequently cooccur in
the same individual and that persons with mental illness
or a history of it have more medical conditions during
their lifetime than the general population.
1 Somatic com-
plaints involving various types of pain,such as headache,
stomach pain,vague,poorly localized pain,and back pain,
are frequent in various psychiatric conditions,but the rela-
tionship between them and the question of whether psy-
choactive drugs similarly improve both conditions have
never been clarified.
The mechanisms for these interactions are largely
unknown,but a variety of indirect and direct mechanisms,
which could also be either concomitants or consequences
of one condition,have been proposed.The importance of
biological vulnerability factors and environment has been
heavily debated, and it was proposed that a substantial
proportion of morbidity may be attributed not to a spe-
cific risk for one disorder,but to few underlying liability
factors that are applicable to both somatic and psychiatric
disorders.
1Thus,even if psychiatric and somatic conditions
do not affect each other, they might still cosegregate if
they share common underlying factors,including genetic
factors.Especially in complex disorders with multifactor-
ial pathophysiological mechanisms,the relevance of genes
has exceeded the simple identification of a disease-
enabling cause and is now focusing on importance for
treatment response,side effects,interactions with the envi-
ronment,and personality factors.It was further proposed
that both the vulnerability for different disorders and the
individual’s interaction with the environment are influ-
enced by genes (“nature and nurture”).
2
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There is increasing knowledge about considerable comor-
bidity between psychiatric and somatic diseases, ques-
tioning whether variations in genes could be predispos-
ing factors for both conditions. With respect to the
multiple interactions between brain and body, investiga-
tions have centered on variants in several candidate genes
for proteins that mediate these interactions and therefore
also have implications in psychiatric disorders. The avail-
able data, although still preliminary and rare, indicate the
importance of polymorphic variants in genes coding for
the serotonin (5-hydroxytryptamine, 5-HT) transporter 
(5-HTT), the 5-HT2A receptor, proinflammatory cytokines,
and the angiotensin-converting enzyme (ACE) in
migraine, fibromyalgia, cardiovascular disorders, and psy-
chiatric conditions. The role played by these various poly-
morphisms remains to be determined, as does whether
they are indicative of common pathophysiological mech-
anisms or identify a subgroup of patients with somatic dis-
orders that are more closely related to psychiatric symp-
toms. Nevertheless, they do at least illustrate the potential
influence of genetic differences on illness course and
treatment outcome, and might be a rational approach to
drug development and treatment paradigms. 
Dialogues Clin Neurosci. 2003;5:129-138.Mechanisms of the interaction 
between brain and body
The dispute over whether the brain or the body pre-
dominates can be traced back to ancient times.Although
Hippocrates (460-377 BC),the legendary father of med-
icine, gave an early description of the brain and recog-
nized that each side of the brain controls the opposite
side of the body, the ultimate conceptual framework of
brain–body interactions was established by the seminal
observations of the French philosopher René Descartes
(1596-1650). He provided the first articulation of the
brain–body interaction by localizing the brain’s contact
with body in the pineal gland,and thus raised the ques-
tion of the brain being the body’s control center.Today,
we are now aware that there are intimate connections
and communications between brain and soma, since
adaptation to stressful stimuli, maintenance of homeo-
stasis, and ultimately survival require a bidirectional
feedback communication among the different compo-
nents.Thus,the combined actions of the central nervous
system (CNS) and closely linked hormonal and immune
systems function as a “supercontroller” with the capac-
ity to regulate not only cognition and behavior,but also
heart and vasculature, metabolism, and fluid and elec-
trolyte balance.
3
Mental stress, either acute or chronic, produces certain
physiological responses via the CNS (Figure 1).The body’s
adaptive responses to stress stimuli are mediated by an
intricate system,which includes the hypothalamus-pitu-
itary-adrenocortical (HPA) axis and the sympathoadrenal
system. Dysregulation of the system by repetitive or
chronic stress may induce continually increased adreno-
cortico-tropic hormone (ACTH) and corticosteroid levels,
increase the production of monoamines and proinflam-
matory cytokines within the brain,and thus contribute to
a variety of somatic and psychiatric disorders including
hypertension,atherosclerosis,functional disorders of the
digestive system,several immunological disorders,affec-
tive disorders, or anxiety.
4 From a clinical point of view,
much evidence has accumulated that disturbances in the
HPA axis with elevated circulating plasma levels of ACTH
and cortisol play a pivotal role in depression.As it is also
known that administered corticosteroids induce hyper-
cholesterolemia,hypertriglyceridemia,and hypertension
and that elevated morning cortisol concentrations are cor-
related with coronary artherosclerosis,
5 a relationship
between depression and vascular diseases seems plausible.
However,in recent years,a paradoxical phenomenon has
emerged from neurobiological studies on the effect of
chronic stress,as a number of studies have provided evi-
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Selected abbreviations and acronyms
ACE angiotensin-converting enzyme
CRH corticotropin-releasing hormone
DA dopamine
FM fibromyalgia
5-HIAA 5-hydroxyindole acetic acid
HPA hypothalamus-pituitary-adrenocortical (axis) 
5-HT 5-hydroxytryptamine (serotonin)
5-HTT serotonin transporter
IL-1  interleukin-1 
NE norepinephrine
TNF-  tumor necrosis factor  
Figure 1. Interactions between brain and body. CRF, corticotropin-releas-
ing factor; ACTH, adrenocorticotropic hormone; E, epinephrine;
NE, norepinephrine; 5-HT, 5-hydroxytryptamine (serotonin); DA,
dopamine; NK, natural killer.
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adence that the adrenal gland is hypoactive in some stress-
related states,resulting in hypocortisolism.This enhanced
negative feedback sensitivity of glucocorticoid receptors
or a persistent lack of cortisol availability can be observed
in posttraumatic stress disorder and in other conditions
such as chronic fatigue syndrome,fibromyalgia (FM),and
rheumatoid arthritis.It was proposed that traumatized or
chronically stressed individuals may have an increased
vulnerability for stress-related somatic disorders.
6
The monoamine neurotransmitter systems, serotonin 
(5-hydroxytryptamine,5-HT),norepinephrine (NE),and
dopamine (DA),which are cornerstones of the hypothe-
ses of psychiatric disorders, play important roles in
mood, cognition, learning, motor activity, vigilance,
reward, sleep, appetite, and cardiovascular function.
Although their most important cell bodies are located in
relatively small areas of the brain or brain stem,axonal
projections are sent throughout the brain along specific
pathways to mediate specific functions; when dysfunc-
tional,they generate many symptoms of psychiatric dis-
orders. On the other hand, axonal projections are also
sent down the spinal cord,where they act as key homeo-
static regulators to vegetative function or sensations
coming from the internal milieu of the body.Thus,NE is
also a major neurotransmitter in postganglionic sympa-
thetic synapses and alterations in function of their trans-
porters or receptors are compromised in cardiomyop-
athy,heart failure,hypertension,and ischemia.
7 
Our understanding of the immunomodulatory activities
of numerous neuroendocrine mediators,such as cortisol,
sex hormones, catecholamines, or corticotropin-releas-
ing hormone (CRH) has advanced substantially.
Proinflammatory cytokines are also expressed in the brain
by microglia,astrocytes,oligodendrocytes,and neurons,
and mediate the response to acute and chronic inflamma-
tory CNS diseases.Products of an activated immune sys-
tem (eg,cytokines) may affect neuroendocrine and central
neurotransmitter processes, and conversely neuroen-
docrine and central neurotransmitter alterations may have
an impact on immune activity.
8 It had been shown that the
immune system acts like a sensory organ informing the
brain of peripheral antigenic challenge,and that immune
activation with increased production of proinflammatory
cytokines,such as interleukin-1β(IL-1β) and tumor necro-
sis factor α(TNF-α),increases the activity of the HPA axis
and leads to altered monoamine turnover in the brain,
thus influencing complex behavioral processes.
9The find-
ings of variations in plasma cytokines in patients with
major depression
10 or schizophrenia
11 are supported by the
facts that some antidepressants suppress the inflammatory
response
10 and clozapine has antiviral properties,at least
in vitro.
12
With respect to the multiple interactions, it becomes
apparent that variations in genes coding for the proteins
that are regulating or modulating these interactions might
have a tremendous influence on the susceptibility for
somatic and psychiatric disorders or for a combined vul-
nerability.Thus,studies that support linkage or associa-
tion of variations in the genes implicated in these candi-
date pathways to psychiatric disorders could also be a hint
to somatic distress.Indeed,it is known that certain inher-
ited metabolic disorders,eg,Wilson disease,can impose
with psychiatric symptoms as their initial—and sometimes
as their only—manifestation and a variety of psychologi-
cal and psychiatric manifestations,ranging from lowering
of IQ to frank psychosis or mood disturbances can be
observed.
13 However, these disorders are rare, and the
majority of psychiatric and somatic diseases are complex
disorders,which means that the underlying pathophysi-
ology is multifactorial with interactions between one or
more genes and environmental factors.
Findings in selected disorders
Migraine
Migraine is one of the most common neurovascular dis-
orders affecting between 16% and 23% of the general
population. Characteristics of the disease are severe
episodes of headache,together with autonomic and neu-
rological symptoms.
14 Despite the rare familial hemi-
plegic migraine, which is probably caused by mutations
in the calcium channel α1-subunit,
15 two main types can
be distinguished: migraine without aura and migraine
with aura.The latter has preceding transient focal neu-
rological symptoms,mostly visual.
Epidemiological studies demonstrate a higher psychiatric
comorbidity for anxiety,personality trait disorders,and
suicide attempts in persons suffering from migraine than
in persons without.
16 Further,the lifetime prevalence of
major depression was approximately three times
increased in patients with migraine with a significant
bidirectional relationship between the two disorders.
17
Migraine is believed to be the manifestation of a heredi-
tary abnormal sensitivity of neurovascular reaction to sud-
den changes in the internal or external environment,or to
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131cyclic changes in the CNS.Although the real underlying
mechanisms remain obscure,there is much support for a
role of 5-HT,which is not only involved in regulation of
behavioral functions,but also in gastrointestinal mobility
and vascular resistance. Thus, acute migraine attacks 
can effectively be treated with triptans, highly selective 
5-HT1B/1D receptor agonists, which act mainly via vaso-
constriction of dilated cerebral blood vessels,inhibition of
the release of neuropeptides such as substance P,and inhi-
bition of nociceptive neurotransmission.Typical antide-
pressants,eg,amitriptyline or fluoxetine,are also effective
in the preventive treatment of migraine,probably via their
influence on the neurotransmitter systems.These findings
are a hint for possible common pathophysiological mech-
anisms for migraine and depression,and lead to the ques-
tion of whether polymorphisms relevant for affective dis-
orders might also be involved in migraine.
Genes of the serotonergic system
Among the most frequently investigated candidate genes
of the serotonergic pathway is the serotonin transporter
(5-HTT), which cleaves the synaptic cleft from neuro-
transmitters and thus limits the duration of 5-HT function.
Two polymorphic sites within the 5-HTT gene are partic-
ularly interesting:one located in the promoter region with
a deletion/insertion variation of 44 bp,creating short (S)
and long (L) alleles,the 5-HTT–linked promoter region
(HTTLPR); and a variable number of tandem repeats
(VNTR) polymorphism,located in the second intron of
the gene.
18The presence of the S allele of the HTTLPR is
associated with decreased 5-HT reuptake,which,in turn,
results in a longer duration of the serotonergic activity.
19
Although the results with psychiatric patients are not con-
clusive,the polymorphism may be of some importance in
anxiety-related personality traits,
20 depression,
21 and suici-
dality.
22 However,for migraine sufferers,no association has
been found to date for this genetic variant of the 5-HTT.
23,24
In contrast,the VNTR polymorphism,whose functional
significance remains to be elucidated,seems to play a role
in migraine, as the frequency of the ST12.10 allele was
increased.
23,24 Moreover, differences were observed
between migraine with and without aura, thus being in
concordance with the assumption that these forms of the
disorder might be etiologically distinct.
24These data sup-
port the view that susceptibility to migraine has a genetic
component,which may,in some cases,be associated with
a locus at or near 5-HTT.
Further studies investigated genetic variations in the 
5-HT receptors.Whereas no association was observed for
the 5-HT2C subtype,
25 a polymorphism in the 5-HT2A
receptor gene (a T to C transition at position 102),which
has been repeatedly associated with psychiatric disorders
and treatment response,
26,27 also seems to be relevant in
migraine.Although the distribution of the 5-HT2AT102C
genotypes could not be directly related to an increased
risk of migraine,the C/C genotypes were more frequently
observed in migraine with aura,
28,29 thus confirming the
previously observed etiologic dichotomy of the two sub-
types.
Genes of the immune system
The association between pain and inflammation has led
physicians to suspect a connection between immuno-
logical mechanisms and headache syndromes for many
years. Several immunological abnormalities, such as
changes in serum levels of complement and immuno-
globulins or increased TNF-α, have been described in
body fluids of patients with migraine and may be related
to susceptibility to increased infection.
30 The cause for
this increased susceptibility is unclear,but was discussed
as a result of chronic stress,a well-known suppressor of
the immune system. Stress relief enhances immune
activity and triggers a burst of circulating vasoactive
neuropeptides (such as substance P or neurokinin A),
which function as mediators of inflammation and poten-
tial precipitators of a migraine attack in vulnerable sub-
jects.
30
It is well known that the production of cytokines is also
regulated by genes,
31 which might in turn have implica-
tions on the age of onset of several disorders as rheuma-
toid arthritis
32 or Alzheimer’s disease.
33 A recent obser-
vation indicated that migraine patients with aura who
are carrying the T/T genotype of the interleukin-1α
C889T polymorphism have about 10 years earlier age of
onset of their migraine attacks.This supports the hypoth-
esis of a genetically driven sterile inflammation as one
etiological factor.
34 Moreover,an association was found
for the cytokines produced by TNF genes with the
TNFβ2 allele, but only in migraine sufferers without
aura.
35 These findings support the assumption that the
abnormalities in immunological parameters are not only
a consequence of the headache attacks, as has been
repeatedly hypothesized, but can also modify the clini-
cal course and the phenotypic expression of the disease.
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FM is a syndrome characterized by chronic widespread,
persistent pain associated with increased tenderness to
palpation due to lowering of the mechanical pain thresh-
old and additional symptoms such as stiffness,fatigue,and
psychological distress.
36 Several additional clinical features
of FM, including depression, anxiety, and sleep distur-
bances,as well as the fact that it runs in families and shows
an increased familial loading with depressive disorders,
have even lead to the suggestion that FM might be a
“depressive spectrum disorder.”
37 This assumption was
further supported by positive therapeutic response to
antidepressant drugs,as well as by the fact that pain per-
ception threshold was found to be decreased during
depression,
38 which was considered as being attributable
to dysfunction in several neurotransmitter systems.
39
The etiology of FM is unknown, but a possible contri-
bution of 5-HT has been suggested on the basis of mul-
tiple biological findings, as for example, low levels of
serum 5-HT
40 and low 5-hydroxyindole acetic acid 
(5-HIAA) levels in cerebrospinal fluid (CSF) of idio-
pathic pain patients.
41 Further,since tryptophan supple-
mentation was shown to improve not only depression
and anxiety,but also somatic pains in a variety of patient
cohorts,the concept of decreased flux through the 5-HT
pathway in FM patients has been proposed.
42 A recent
finding in FM patients demonstrated strong negative
correlations between the serum concentrations of sub-
stance P and 5-HIAA and between substance P and
serum tryptophan.
43These findings support the hypoth-
esis of a systemic involvement of 5-HT and substance P
in FM.
Genes of the serotonergic system
As regards the 5-HTT gene HTTLPR polymorphism,
we have observed a higher frequency of the SS genotype
in FM patients compared with healthy controls and,
interestingly, patients with the SS genoytpe exhibited
higher levels of depression and psychological distress.
44
This preliminary finding was recently confirmed in
patients of two different ethnicities (Jewish and Arabian
populations), and extended by the observation that the
FM patients were characterized by extremes of tem-
perament extensions,especially harm avoidance.
45 These
results are in concordance with our previous findings,as
the personality trait of harm avoidance and neuroticism
are correlates of clinical depression and anxiety-related
disorders.Taken together,these findings suggest that the
correlation between FM and the short allele (S) of the
HTTLPR polymorphism could either (i) be indicative
of common pathophysiological mechanisms with depres-
sion; or (ii) be mediated by depression- and anxiety-
related traits, and thus indicative of a subgroup of
patients more likely to suffer depression.
The 5-HT2A receptor also seems to be of great interest,
since a recent finding with animal experiments suggested
that the 5-HT2A receptor is involved in the thermal hyper-
algesic mechanism of 5-HT in periphery.
46The facts that
the cerebral expressions of the 5-HT2A, 5-HT2C, and 
5-HT6 receptors in rats are colocalized extensively with
synthesis and expression of the neuropeptides
enkephalin, substance P, and dynorphin
47 and that sub-
stance P immunoreactivity was found to be higher in
lumbar CSF of FM patients
48 further highlight the impor-
tance of the 5-HT2 receptor family in the underlying
pathophysiological process of this disorder. In a large
cohort of FM patients,we showed a significantly different
genotype distribution in FM patients with a decrease in
T/T and an increase in T/C and C/C genotypes of the 5-
HT2A C102T polymorphism.Although there were no cor-
relations between genotype and age of onset,duration of
the disorder,or psychopathological symptoms rated on
the Beck Depression Inventory,we found a reduced pain
threshold in patients with the T/T genotype.
49 Recently,
the significant correlation between the 5-HT2ATT geno-
type and increased pain perception was replicated in a dif-
ferent sample,but no overall differences between patients
and controls were observed.
50 Although these findings
indicate that the 102T allele of the 5-HT2A receptor gene
polymorphism is involved in the complex circuits of noci-
ception, this genetic variant is apparently not directly
involved in the etiology of FM,but is supposed to be in
linkage disequilibrium with the true variant nearby,which
remains to be unraveled.
Depression and cardiovascular disorders
There is burgeoning literature on the relationship
between mood disorders and cardiovascular disease
(CVD).Several studies have demonstrated that depres-
sion increases the risk of developing cardiac disease, in
particular coronary artery disease, and to worsen prog-
nosis after myocardial infarction.
51The impact of depres-
sion was mostly related to the premorbid cardiac disease
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during the first 6 months following myocardial infarc-
tion, but a recent analysis has shown that depression
increases the risk for cardiac mortality independently of
baseline cardiac status.
52
The mechanisms of increased cardiac risk attributable
to depressive illness are at present uncertain, but acti-
vation of the sympathetic nervous system with increased
levels of monoamines,
53 exaggerated platelet activity,
and/or enhanced inflammatory-mediated atherogenesis
are likely to be of primary importance.
51,53
The 5-HTT gene
Activation of platelets is pivotal to the development of
hemostasis and thrombosis,and plays a role in the devel-
opment of atherosclerosis via multiple interactions with
endothelial vessel walls and plasma coagulation factors.
54
However, patients with depression also exhibit altered
platelet function and increased aggregation, and thus
predispose depressed patients to clotting diathesis.
51
Thus, it was proposed that increased platelet activation
in depression might be the mechanism by which depres-
sion becomes a significant risk factor for CVD. The
mechanisms by which platelet activation is increased in
depression remain unknown,but one possibility involves
the 5-HT system,because 5-HT activates platelet aggre-
gation thus leading to thrombus formation.
55 In this con-
text, it would be remarkable if the 5-HTTLPR poly-
morphism influenced the degree of platelet activation,
as homozygosity for the long allele (L/L) could be asso-
ciated with platelet activation, increased platelet factor
4, and thromboglobulin levels in elderly, depressed
patients.
56 On the basis of this finding, it was proposed
that platelets in persons with the L/L genotype are more
efficient in uptake and storage of 5-HT in their dense
granules,followed by increased 5-HT release upon acti-
vation,which may consequently lead to a greater throm-
bus formation and finally to myocardial infarction.
56
The possible importance of the 5-HTTLPR polymor-
phism was further underlined by a study investigating the
impact of indices of CNS 5-HT function on cardiovascu-
lar reactivity to mental stress.The study was carried out
in healthy volunteers and showed that persons with one
or two L alleles had higher CSF levels of the 5-HT
metabolite 5-HIAA than those with the S/S genotype and
exhibited greater blood pressure and heart rate responses
to a mental stress protocol.Thus,the 5-HTTLPR poly-
morphism affects not only central 5-HT function,but also
seems to be involved in the regulation of biobehavioral
characteristics.
57
The G-protein– 3 subunit (G 3) gene
Neurotransmitter molecules do not cross the post-
synaptic membranes,but induce a cascade of reactions
via their initial binding to surface receptors within the
postsynaptic membrane,which are often coupled to gua-
nine-nucleotide–binding proteins (G proteins).These G
proteins represent initial regulatory components in trans-
membrane signaling and are thus key elements in signal
transduction,regulating many biological responses.
58 In
one subunit of these G proteins,the Gβ3 subunit,a poly-
morphism was identified (a C to T exchange at position
825 in exon 10),which leads to the occurrence of a splice
variant (Gβ3-s) with deletion of 41 amino acids.It is now
fairly well established that the T allele of this polymor-
phism, which results in increased ion flux across the
membrane and increased signal transduction,is associ-
ated with hypertension and obesity.
59,60 However, this
genetic variant is not just important for somatic disor-
ders, because we also found an increased frequency of
the T allele in patients with affective psychosis.
61 In an
extended sample, using the DNA of 201 patients with
major depression without increased proportions of
hypertensives, we were able to replicate our previous
results of increased frequency of allele T and increase in
TT homozygotes (χ
2=14.8; df=2; P=0.0006). Thus, our
results are consistent with the hypothesis that distur-
bances in the signal transduction cascade on the level of
G proteins are involved as contributing factor in the
pathophysiology of major depression,despite its impor-
tance in essential hypertension.
62
The ACE gene 
Angiotensin-converting enzyme (ACE) is a zinc metal-
lopeptidase involved in blood pressure regulation via the
angiotensin-renin cascade, generating angiotensin II
(ATII) from angiotensin I, and via degradation of the
powerful vasodilator bradykinin. However, the effects
of this enzyme are not restricted to the vasculature, as
several studies have demonstrated that ACE might also
be involved in HPA axis regulation and catecholamine
production via the generation of ATII
63 and is thus
required for sympathoadrenal activation during stress.
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Further evidence suggests an involvement of the brain
renin-angiotensin system in regulation of mood,because
of the colocalization of angiotensin with dopamine-syn-
thesizing neurons,
64 the fact that ACE is involved in the
metabolism of the neuropeptide substance P, which, in
turn, is supposed to play a role in depression,
65 and the
clinical observation that the application of ACE
inhibitors in hypertensives can induce euphoric or
depressive states.
66
The ACE I/D polymorphism is characterized by the
insertion (I) or deletion (D) of a 287-bp sequence within
intron 16 of the gene;and the D allele is associated with
increased levels of circulating ACE.
67 Numerous studies
have implicated the ACE DD genotype with cardiovas-
cular disorders,including myocardial infarction,
68 hyper-
tension, and left ventricular hypertrophy,
69 and also
affective disorders,
70 but these associations were not con-
sistent in all studies.A review of the literature revealed
a moderate degree of increased risk for myocardial
infarction and coronary heart disease associated with the
ACE DD genotype in most populations.
71 Recently, the
impact of the ACE DD genotype on myocardial infarc-
tion was reevaluated using the paradigm of gene–gene
interaction between the ACE gene variants together
with the C825T polymorphism in the Gβ3 subunit in
patients with coronary artery disease with and without
myocardial infarction. In the combined analysis of the
ACE and Gβ3 polymorphisms, the highest relative risk
(odds ratio [OR] 7.5) was found in Gβ3-TT/ACE-DD
carriers,suggesting that the interaction between the Gβ3
825T and the ACE D alleles increases the risk more than
sevenfold and are thus a possible contributing factor for
myocardial infarction.
72
On the basis of our own previous results regarding an
association of the Gβ3 825T allele with affective disor-
ders
61 and a possible influence of the ID polymorphism
of the ACE gene polymorphism on therapeutic outcome
in affective disorders,
73 we studied the interaction of both
gene variants in 201 patients with unipolar major depres-
sion and 161 ethnically matched controls. Interestingly,
in depressed patients,we observed a combined action of
ACE and Gβ3 genotypes: ACE-ID and DD/Gβ3-TT
carriers were more than four times more frequent in the
depressed group than in the controls (crude OR=5.83;
95% confidence interval 1.99–17.08;P=0.0002).
62As our
study was carried out in depressed patients without seri-
ous cardiovascular impairment,we are currently unable
to predict whether this combined action of the ACE
ID/DD and Gβ3 TT genotype increases the risk for both
disorders. Nevertheless, our study is the first report of
the same allelic combination of two genes that increase
the risk for myocardial infarction
72 and the vulnerability
for depressive disorder, and this could be one missing
link for the interaction.
Summary and conclusion
With respect to the multiple interactions between brain
and body,it is plausible that polymorphisms in genes cod-
ing for proteins that regulate or modulate these interac-
tions have a tremendous influence on susceptibility,
pathophysiology,or comorbidity of somatic and psychi-
atric disorders.Thus,variants in several candidate genes
that have repeatedly been associated with psychiatric dis-
orders may also be successfully investigated in somatic
disorders or vice versa.The available data,although being
still preliminary and rare,implicate the importance of the
serotonergic and catecholaminergic systems,the various
components of the HPA axis as well as the immune sys-
tem and ACE as possible common genetic risk factors for
psychiatric and somatic disorders.Interestingly,polymor-
phisms within the 5-HTT and 5-HT2A receptor gene were
found to be related to migraine, FM, cardiovascular
events,and several psychiatric conditions,thus underlin-
ing the multiple effects of this neurotransmitter in brain
and periphery.Neither the immunological system nor the
ACE gene have yet been extensively investigated,but a
similar importance for these proteins could be antici-
pated.
The role played by these various polymorphisms
remains to be determined.Some may not be specific for
disorders, but could increase susceptibility to the disor-
der and induce endophenotypic vulnerability markers.
Although it is questionable whether these findings have
immediate clinical implications,they do at least illustrate
the potential influence of genetic differences on illness
course and treatment outcome, and help elucidate the
biological underpinnings of the diseases, which allows
a more rationale approach to drug development and
treatment paradigms. ❏Basic research
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Factores de riesgo genéticos comunes a
trastornos psiquiátricos y somáticos
Existe un conocimiento creciente acerca de la
importante comorbilidad entre las enfermedades
psiquiátricas y somáticas, lo que permite pregun-
tarse si las variaciones genéticas podrían constituir
factores predisponentes para ambas condiciones.
En relación con las múltiples interacciones entre el
cerebro y el cuerpo, las investigaciones se han cen-
trado en variantes de algunos genes candidato
para proteínas que median estas interacciones y
que de esta manera tendrían participación en los
trastornos psiquiátricos. Los datos disponibles, aun-
que todavía preliminares y escasos, indican la
importancia que tienen las variantes polimórficas
en los genes que codifican el transportador de
serotonina (5-hidroxitriptamina, 5-HT), el receptor
5-HT2A, las citoquinas proinflamatorias y la enzima
convertidora de angiotensina (ECA) en la migraña,
la fibromialgia, las enfermedades cardiovasculares
y los cuadros psiquiátricos. Queda por determinar
el papel que juegan estos diversos polimorfismos;
ya que pueden ser indicativos de mecanismos fisio-
patológicos comunes o bien pueden servir para
identificar un subgrupo de pacientes que presen-
ten trastornos somáticos muy relacionados con sín-
tomas psiquiátricos. No obstante, ellos ilustran al
menos la potencial influencia de las diferencias
genéticas en el curso de la enfermedad y en la evo-
lución del tratamiento, y podrían proporcionar una
aproximación racional para el desarrollo de fárma-
cos y esquemas terapéuticos.
Facteurs de risque génétique communs aux
maladies psychiatriques et somatiques
Les connaissances sur la comorbidité très importante
entre les maladies psychiatriques et somatiques ont
progressé, posant la question de l’influence des
variations génétiques comme facteurs prédisposants
à ces deux types de pathologies. Dans le cadre des
interactions multiples entre le corps et le cerveau,
l’étude s’est surtout portée sur les variantes de plu-
sieurs gènes candidats codant pour les protéines
permettant la transmission des neuromodulations,
et qui pourraient de ce fait être impliquées dans les
troubles psychiatriques. Les données disponibles,
bien qu’encore préliminaires et peu nombreuses,
soulignent l’importance des variants génétiques
polymorphiques codant pour le transporteur de la
sérotonine (5-HTT), le récepteur 5-HT2A, les cyto-
kines pro-inflammatoires et l’enzyme de conversion
de l’angiotensine (ECA) dans la migraine, la fibro-
myalgie, les maladies cardio-vasculaires et les mala-
dies psychiatriques. Il reste encore à déterminer si le
rôle joué par ces divers polymorphismes reflète des
mécanismes physiopathologiques communs ou s’il
identifie un sous-groupe de patients atteints de
troubles somatiques apparentés plus étroitement
aux symptômes psychiatriques. À tout le moins, ces
polymorphismes illustrent l’influence potentielle des
variations génétiques sur l’évolution de la maladie
ou l’issue du traitement et, à ce titre, pourraient
fournir une approche rationnelle pour le dévelop-
pement de médicaments et l’établissement de sché-
mas thérapeutiques.Common genetic risk factors - Bondy Dialogues in Clinical Neuroscience - Vol 5 . No.2 . 2003
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